Vivani Medical, Inc. (VANI)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 23, 2026

Verified against EDGAR
Total Assets
$41.6M
Stockholders' Equity
$19.0M
Cash & Equivalents
$19.9M
Long-Term Debt
—

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, Vivani Medical, Inc. reported net income of -$6.4M and total assets of $41.6M. Every figure below is taken directly from Vivani Medical, Inc.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2016–FY2025 · as reported

$8.0M-$13.6M-$35.1M
FY2016FY2019FY2022FY2025
Revenue$0Net income-$26.6M
FY2016 revenue
$4.0M
FY2025 revenue
$0

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$0-$26.6M
FY2024$0-$23.5M
FY2023—-$25.7M
FY2022—-$13.9M
FY2021—-$12.8M
FY2020—-$14.9M
FY2019$3.4M-$33.6M
FY2018$6.9M-$35.1M
FY2017$8.0M-$28.5M
FY2016$4.0M-$33.2M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 29, 2026on EDGAR ↗
8-KSep 16, 2026on EDGAR ↗
8-KAug 17, 2026on EDGAR ↗
8-KAug 13, 2026on EDGAR ↗
10-QAug 13, 2026on EDGAR ↗
8-KAug 6, 2026on EDGAR ↗
8-KJul 16, 2026on EDGAR ↗
8-KJul 7, 2026on EDGAR ↗
8-KJun 30, 2026on EDGAR ↗
8-KJun 4, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$41.6Msource ↗
Stockholders’ Equity$19.0Msource ↗
Cash & Equivalents$19.9Msource ↗
Long-Term Debt—source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue—source ↗
Net Income-$6.4Msource ↗
Operating Income-$6.9Msource ↗
Gross Profit—source ↗
Cost of Revenue—source ↗
R&D Expense$4.5Msource ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.07source ↗
EPS (basic)$-0.07source ↗
Shares Outstanding90.2Msource ↗
Cash from Operations-$6.0Msource ↗
Cash from Financing$5.8Msource ↗
Cash from Investing-$99,000source ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
3
Sells
0
Net shares
+4.0M

Restatement history

Point-in-time

18 of 290 annual fact-keys were materially restated between filings: what Vivani Medical, Inc. first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.

See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.

Deeper fundamentals

A free API key reaches VANI’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/VANI

MCP tool: get_sec_fundamentals ticker=VANI

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/VANI/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=VANI as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/fundamentals/VANI/history

MCP tool: get_fundamentals_history ticker=VANI

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
https://api.distillmarkets.com/api/v1/sec/financial-health/VANI

MCP tool: get_financial_health ticker=VANI

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.